{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:44:50Z","timestamp":1793839490131,"version":"4.6.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T00:00:00Z","timestamp":1581379200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T00:00:00Z","timestamp":1581379200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["31_166430\/1"],"award-info":[{"award-number":["31_166430\/1"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI16\/00217-R-FEDER"],"award-info":[{"award-number":["PI16\/00217-R-FEDER"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RTI2018-094211-B-100-FEDER"],"award-info":[{"award-number":["RTI2018-094211-B-100-FEDER"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cerebrospinal fluid (CSF) is mainly produced by the choroid plexus (CP) located in brain ventricles. Although derived from blood plasma, it is nearly protein-free (~\u2009250-fold less) and contains about 2\u201320-fold less free amino acids, with the exception of glutamine (Gln) which is nearly equal. The aim of this study was to determine which amino acid transporters are expressed in mouse CP epithelium in order to gain understanding about how this barrier maintains the observed amino acid concentration gradient.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Expression of amino acid transporters was assessed in isolated choroid plexuses (CPs) by qRT-PCR followed by localization studies using immunofluorescence with specific antibodies. The impact of LAT2 (<jats:italic>Slc7a8<\/jats:italic>) antiporter deletion on CSF amino acids was determined.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The purity of isolated choroid plexuses was tested on the mRNA level using specific markers, in particular transthyretin (Ttr) that was enriched 330-fold in CP compared to cerebral tissue. In a first experimental round, 14 out of 32 <jats:italic>Slc<\/jats:italic> amino acid transporters tested on the mRNA level by qPCR were selected for further investigation. Out of these, five were considered highly expressed, SNAT1 (<jats:italic>Slc38a1<\/jats:italic>), SNAT3 (<jats:italic>Slc38a3<\/jats:italic>), LAT2 (<jats:italic>Slc7a8<\/jats:italic>), ASC1 (<jats:italic>Slc7a10<\/jats:italic>) and SIT1 (<jats:italic>Slc6a20b<\/jats:italic>). Three of them were visualized by immunofluorescence: SNAT1 (<jats:italic>Slc38a1<\/jats:italic>), a neutral amino acid-Na<jats:sup>+<\/jats:sup> symporter, found at the blood side basolateral membrane of CP epithelium, while SNAT3 (<jats:italic>Slc38a3<\/jats:italic>), an amino acid-Na<jats:sup>+<\/jats:sup> symporter and H<jats:sup>+<\/jats:sup> antiporter, as well as LAT2 (<jats:italic>Slc7a8<\/jats:italic>), a neutral amino acid antiporter, were localized at the CSF-facing luminal membrane. In a LAT2 knock-out mouse model, CSF Gln was unchanged, whereas other amino acids normally 2\u201320-fold lower than in plasma, were increased, in particular the LAT2 uptake substrates leucine (Leu), valine (Val) and tryptophan (Trp) and some other amino acids such as glutamate (Glu), glycine (Gly) and proline (Pro).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>These results suggest that Gln is actively transported by SNAT1 from the blood into CP epithelial cells and then released luminally into CSF via SNAT3 and LAT2. Its efflux via LAT2 may drive the reuptake from the CSF of essential amino acid substrates of this antiporter and thereby participates to maintaining the amino acid gradient between plasma and CSF.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12987-020-0178-x","type":"journal-article","created":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T17:05:41Z","timestamp":1581440741000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Choroid plexus LAT2 and SNAT3 as partners in CSF amino acid homeostasis maintenance"],"prefix":"10.1186","volume":"17","author":[{"given":"Elena","family":"Dolgodilina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone M.","family":"Camargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Palac\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3250-9824","authenticated-orcid":false,"given":"Francois","family":"Verrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,11]]},"reference":[{"issue":"1","key":"178_CR1","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/2045-8118-11-26","volume":"11","author":"SB Hladky","year":"2014","unstructured":"Hladky SB, Barrand MA. Mechanisms of fluid movement into, through and out of the brain: evaluation of the evidence. Fluids Barriers CNS. 2014;11(1):26.","journal-title":"Fluids Barriers CNS"},{"issue":"4","key":"178_CR2","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1152\/physrev.00004.2013","volume":"93","author":"HH Damkier","year":"2013","unstructured":"Damkier HH, Brown PD, Praetorius J. Cerebrospinal fluid secretion by the choroid plexus. Physiol Rev. 2013;93(4):1847\u201392.","journal-title":"Physiol Rev"},{"issue":"4","key":"178_CR3","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.neuroscience.2004.07.003","volume":"129","author":"PD Brown","year":"2004","unstructured":"Brown PD, Davies SL, Speake T, Millar ID. Molecular mechanisms of cerebrospinal fluid production. Neuroscience. 2004;129(4):955\u201368.","journal-title":"Neuroscience"},{"issue":"3","key":"178_CR4","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/j.1471-4159.1975.tb07680.x","volume":"24","author":"TL Perry","year":"1975","unstructured":"Perry TL, Hansen S, Kennedy J. CSF amino acids and plasma-CSF amino acid ratios in adults 1. J Neurochem. 1975;24(3):587\u20139.","journal-title":"J Neurochem"},{"issue":"2","key":"178_CR5","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1471-4159.1977.tb09621.x","volume":"29","author":"EHF McGale","year":"1977","unstructured":"McGale EHF, Pye IF, Stonier C, Hutchinson EC, Aber GM. Studies of the inter-relationship between cerebrospinal fluid and plasma amino acid concentrations in normal individuals. J Neurochem. 1977;29(2):291\u20137.","journal-title":"J Neurochem"},{"issue":"1","key":"178_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/ana.410280105","volume":"28","author":"TL Perry","year":"1990","unstructured":"Perry TL, Krieger C, Hansen S, Eisen A. Amyotrophic lateral sclerosis: amino acid levels in plasma and cerebrospinal fluid. Ann Neurol. 1990;28(1):12\u20137.","journal-title":"Ann Neurol"},{"issue":"1","key":"178_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/ana.410280106","volume":"28","author":"JD Rothstein","year":"1990","unstructured":"Rothstein JD, Tsai G, Kuncl RW, Clawson L, Cornblath DR, Drachman DB, et al. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann Neurol. 1990;28(1):18\u201325.","journal-title":"Ann Neurol"},{"issue":"1","key":"178_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1600-0404.1993.tb04186.x","volume":"88","author":"W Camu","year":"1993","unstructured":"Camu W, Billiard M, Baldy-Moulinier M. Fasting plasma and CSF amino acid levels in amyotrophic lateral sclerosis: a subtype analysis. Acta Neurol Scand. 1993;88(1):51\u20135.","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"178_CR9","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/BF01273153","volume":"103","author":"J M\u00e1lly","year":"1996","unstructured":"M\u00e1lly J, Baranyi M, Vizi ES. Change in the concentrations of amino acids in CSF and serum of patients with essential tremor. J Neural Transm. 1996;103(5):555\u201360.","journal-title":"J Neural Transm"},{"issue":"2\u20133","key":"178_CR10","first-page":"269","volume":"105","author":"FJ Jimenez-Jimenez","year":"1998","unstructured":"Jimenez-Jimenez FJ, Molina JA, Gomez P, Vargas C, de Bustos F, Benito-Leon J, et al. Neurotransmitter amino acids in cerebrospinal fluid of patients with Alzheimer\u2019s disease. J Neural Transm. 1998;105(2\u20133):269\u201377.","journal-title":"J Neural Transm"},{"issue":"2","key":"178_CR11","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1176\/ajp.149.2.251","volume":"149","author":"N Pomara","year":"1992","unstructured":"Pomara N, Singh R, Deptula D, Chou JC, Schwartz MB, LeWitt PA. Glutamate and other CSF amino acids in Alzheimer\u2019s disease. Am J Psychiatry. 1992;149(2):251\u20134.","journal-title":"Am J Psychiatry"},{"issue":"2\u20133","key":"178_CR12","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s007020050057","volume":"105","author":"JA Molina","year":"1998","unstructured":"Molina JA, Jimenez-Jimenez FJ, Vargas C, Gomez P, de Bustos F, Orti-Pareja M, et al. Cerebrospinal fluid levels of non-neurotransmitter amino acids in patients with Alzheimer\u2019s disease. J Neural Transm. 1998;105(2\u20133):279\u201386.","journal-title":"J Neural Transm"},{"key":"178_CR13","doi-asserted-by":"publisher","first-page":"e561","DOI":"10.1038\/tp.2015.52","volume":"5","author":"C Madeira","year":"2015","unstructured":"Madeira C, Lourenco MV, Vargas-Lopes C, Suemoto CK, Brandao CO, Reis T, et al. d-serine levels in Alzheimer\u2019s disease: implications for novel biomarker development. Transl Psychiatry. 2015;5:e561.","journal-title":"Transl Psychiatry"},{"key":"178_CR14","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.neurobiolaging.2016.03.017","volume":"42","author":"EA Biemans","year":"2016","unstructured":"Biemans EA, Verhoeven-Duif NM, Gerrits J, Claassen JA, Kuiperij HB, Verbeek MM. CSF d-serine concentrations are similar in Alzheimer\u2019s disease, other dementias, and elderly controls. Neurobiol Aging. 2016;42:213\u20136.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"178_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","volume":"37","author":"NJ Abbott","year":"2010","unstructured":"Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ. Structure and function of the blood\u2013brain barrier. Neurobiol Dis. 2010;37(1):13\u201325.","journal-title":"Neurobiol Dis"},{"issue":"3","key":"178_CR16","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1021\/acs.molpharmaceut.7b00852","volume":"15","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Tachikawa M, Uchida Y, Terasaki T. Drug clearance from cerebrospinal fluid mediated by organic anion transporters 1 (Slc22a6) and 3 (Slc22a8) at arachnoid membrane of rats. Mol Pharm. 2018;15(3):911\u201322.","journal-title":"Mol Pharm"},{"issue":"4","key":"178_CR17","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1124\/dmd.112.050344","volume":"41","author":"K Yasuda","year":"2013","unstructured":"Yasuda K, Cline C, Vogel P, Onciu M, Fatima S, Sorrentino BP, et al. Drug transporters on arachnoid barrier cells contribute to the blood\u2013cerebrospinal fluid barrier. Drug Metab Dispos. 2013;41(4):923\u201331.","journal-title":"Drug Metab Dispos"},{"issue":"10","key":"178_CR18","doi-asserted-by":"publisher","first-page":"8974","DOI":"10.1074\/jbc.M413027200","volume":"280","author":"H Takanaga","year":"2005","unstructured":"Takanaga H, Mackenzie B, Suzuki Y, Hediger MA. Identification of mammalian proline transporter SIT1 (SLC6A20) with characteristics of classical system imino. J Biol Chem. 2005;280(10):8974\u201384.","journal-title":"J Biol Chem"},{"issue":"2","key":"178_CR19","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1124\/jpet.108.149831","volume":"329","author":"A Dahlin","year":"2009","unstructured":"Dahlin A, Royall J, Hohmann JG, Wang J. Expression profiling of the solute carrier gene family in the mouse brain. J Pharmacol Exp Ther. 2009;329(2):558\u201370.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"178_CR20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/2045-8118-8-10","volume":"8","author":"F Marques","year":"2011","unstructured":"Marques F, Sousa JC, Coppola G, Gao F, Puga R, Brentani H, et al. Transcriptome signature of the adult mouse choroid plexus. Fluids Barriers CNS. 2011;8(1):10.","journal-title":"Fluids Barriers CNS"},{"key":"178_CR21","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3389\/fphar.2012.00154","volume":"3","author":"HTB Ho","year":"2012","unstructured":"Ho HTB, Dahlin A, Wang J. Expression profiling of solute carrier gene families at the blood\u2013CSF barrier. Front Pharmacol. 2012;3:154.","journal-title":"Front Pharmacol"},{"issue":"4\u20135","key":"178_CR22","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0197-0186(03)00013-5","volume":"43","author":"J Xiang","year":"2003","unstructured":"Xiang J, Ennis SR, Abdelkarim GE, Fujisawa M, Kawai N, Keep RF. Glutamine transport at the blood\u2013brain and blood\u2013cerebrospinal fluid barriers. Neurochem Int. 2003;43(4\u20135):279\u201388.","journal-title":"Neurochem Int"},{"key":"178_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12987-015-0006-x","volume":"12","author":"S-I Akanuma","year":"2015","unstructured":"Akanuma S-I, Sakurai T, Tachikawa M, Kubo Y, Hosoya K-I. Transporter-mediated l-glutamate elimination from cerebrospinal fluid: possible involvement of excitatory amino acid transporters expressed in ependymal cells and choroid plexus epithelial cells. Fluids Barriers CNS. 2015;12:11.","journal-title":"Fluids Barriers CNS"},{"key":"178_CR24","unstructured":"Font-Llitj\u00f3s M. Renal reabsorption of amino acids: SLC7A9 mutation analysis, the type B cystinuria gene and characterization of a Knockout murin model Slc7a8. Doctoral thesis, University of Barcelona. 2005."},{"issue":"11","key":"178_CR25","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1177\/0271678X15609331","volume":"36","author":"E Dolgodilina","year":"2016","unstructured":"Dolgodilina E, Imobersteg S, Laczko E, Welt T, Verrey F, Makrides V. Brain interstitial fluid glutamine homeostasis is controlled by blood-brain barrier SLC7A5\/LAT1 amino acid transporter. J Cereb Blood Flow Metab. 2016;36(11):1929\u201341.","journal-title":"J Cereb Blood Flow Metab"},{"key":"178_CR26","first-page":"e4285","volume":"69","author":"JF Bowyer","year":"2012","unstructured":"Bowyer JF, Thomas M, Patterson TA, George NI, Runnells JA, Levi MS. A visual description of the dissection of the cerebral surface vasculature and associated meninges and the choroid plexus from rat brain. J Vis Exp. 2012;69:e4285.","journal-title":"J Vis Exp"},{"key":"178_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.pharmthera.2015.03.001","volume":"151","author":"NA Warfel","year":"2015","unstructured":"Warfel NA, Kraft AS. PIM kinase (and Akt) biology and signaling in tumors. Pharmacol Ther. 2015;151:41\u20139.","journal-title":"Pharmacol Ther"},{"issue":"10","key":"178_CR28","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.tibs.2018.05.003","volume":"43","author":"P Kandasamy","year":"2018","unstructured":"Kandasamy P, Gyimesi G, Kanai Y, Hediger MA. Amino acid transporters revisited: new views in health and disease. Trends Biochem Sci. 2018;43(10):752\u201389.","journal-title":"Trends Biochem Sci"},{"issue":"2","key":"178_CR29","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.brainres.2005.06.039","volume":"1052","author":"X Xie","year":"2005","unstructured":"Xie X, Dumas T, Tang L, Brennan T, Reeder T, Thomas W, et al. Lack of the alanine\u2013serine\u2013cysteine transporter 1 causes tremors, seizures, and early postnatal death in mice. Brain Res. 2005;1052(2):212\u201321.","journal-title":"Brain Res"},{"issue":"7","key":"178_CR30","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1038\/jcbfm.2011.21","volume":"31","author":"N Ruderisch","year":"2011","unstructured":"Ruderisch N, Virgintino D, Makrides V, Verrey F. Differential axial localization along the mouse brain vascular tree of luminal sodium-dependent glutamine transporters Snat1 and Snat3. J Cereb Blood Flow Metab. 2011;31(7):1637\u201347.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"36","key":"178_CR31","doi-asserted-by":"publisher","first-page":"26552","DOI":"10.1074\/jbc.M604049200","volume":"281","author":"E Fern\u00e1ndez","year":"2006","unstructured":"Fern\u00e1ndez E, Jim\u00e9nez-Vidal M, Calvo M, Zorzano A, Tebar F, Palac\u00edn M, et al. The structural and functional units of heteromeric amino acid transporters: the heavy subunit rBAT dictates oligomerization of the heteromeric amino acid transporters. J Biol Chem. 2006;281(36):26552\u201361.","journal-title":"J Biol Chem"},{"issue":"6","key":"178_CR32","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1681\/ASN.2017111205","volume":"29","author":"C Vilches","year":"2018","unstructured":"Vilches C, Boiadjieva-Knopfel E, Bodoy S, Camargo S, Lopez de Heredia M, Prat E, et al. Cooperation of antiporter LAT2\/CD98hc with uniporter TAT1 for renal reabsorption of neutral amino acids. J Am Soc Nephrol. 2018;29(6):1624\u201335.","journal-title":"J Am Soc Nephrol"},{"key":"178_CR33","doi-asserted-by":"publisher","first-page":"e31511","DOI":"10.7554\/eLife.31511","volume":"7","author":"M Espino Guarch","year":"2018","unstructured":"Espino Guarch M, Font-Llitj\u00f3s M, Murillo-Cuesta S, Errasti- Murugarren E, Celaya AM, Girotto G, et al. Mutations in L-type amino acid transporter-2 support SLC7A8 as a novel gene involved in age-related hearing loss. eLife. 2018;7:e31511.","journal-title":"eLife"},{"issue":"49","key":"178_CR34","doi-asserted-by":"publisher","first-page":"34948","DOI":"10.1074\/jbc.274.49.34948","volume":"274","author":"G Rossier","year":"1999","unstructured":"Rossier G, Meier C, Bauch C, Summa V, Sordat B, Verrey F, et al. LAT2, a new basolateral 4F2hc\/CD98-associated amino acid transporter of kidney and intestine. J Biol Chem. 1999;274(49):34948\u201354.","journal-title":"J Biol Chem"},{"issue":"2","key":"178_CR35","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/0006-8993(84)90250-6","volume":"302","author":"T Masuzawa","year":"1984","unstructured":"Masuzawa T, Ohta T, Kawamura M, Nakahara N, Sato F. Immunohistochemical localization of Na+, K+-ATPase in the choroid plexus. Brain Res. 1984;302(2):357\u201362.","journal-title":"Brain Res"},{"issue":"14","key":"178_CR36","doi-asserted-by":"publisher","first-page":"5278","DOI":"10.1073\/pnas.87.14.5278","volume":"87","author":"AE Lindsey","year":"1990","unstructured":"Lindsey AE, Schneider K, Simmons DM, Baron R, Lee BS, Kopito RR. Functional expression and subcellular localization of an anion exchanger cloned from choroid plexus. Proc Natl Acad Sci. 1990;87(14):5278\u201382.","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"178_CR37","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1042\/BJ20110759","volume":"439","author":"D Braun","year":"2011","unstructured":"Braun D, Wirth EK, Wohlgemuth F, Reix N, Klein MO, Gruters A, et al. Aminoaciduria, but normal thyroid hormone levels and signalling, in mice lacking the amino acid and thyroid hormone transporter Slc7a8. Biochem J. 2011;439(2):249\u201355.","journal-title":"Biochem J"},{"issue":"4","key":"178_CR38","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1093\/emboj\/21.4.580","volume":"21","author":"C Meier","year":"2002","unstructured":"Meier C, Ristic Z, Klauser S, Verrey F. Activation of system L heterodimeric amino acid exchangers by intracellular substrates. EMBO J. 2002;21(4):580\u20139.","journal-title":"EMBO J"},{"issue":"1","key":"178_CR39","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jchemneu.2011.09.006","volume":"43","author":"A Lee","year":"2012","unstructured":"Lee A, Anderson AR, Rayfield AJ, Stevens MG, Poronnik P, Meabon JS, et al. Localisation of novel forms of glutamate transporters and the cystine-glutamate antiporter in the choroid plexus: implications for CSF glutamate homeostasis. J Chem Neuroanat. 2012;43(1):64\u201375.","journal-title":"J Chem Neuroanat"},{"issue":"26","key":"178_CR40","doi-asserted-by":"publisher","first-page":"23720","DOI":"10.1074\/jbc.M212718200","volume":"278","author":"B Mackenzie","year":"2003","unstructured":"Mackenzie B, Schafer MK, Erickson JD, Hediger MA, Weihe E, Varoqui H. Functional properties and cellular distribution of the system A glutamine transporter SNAT1 support specialized roles in central neurons. J Biol Chem. 2003;278(26):23720\u201330.","journal-title":"J Biol Chem"},{"issue":"1","key":"178_CR41","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1046\/j.1471-4159.2003.01981.x","volume":"87","author":"JW Deitmer","year":"2003","unstructured":"Deitmer JW, Broer A, Broer S. Glutamine efflux from astrocytes is mediated by multiple pathways. J Neurochem. 2003;87(1):127\u201335.","journal-title":"J Neurochem"},{"issue":"6","key":"178_CR42","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1002\/glia.23133","volume":"65","author":"AC Todd","year":"2017","unstructured":"Todd AC, Marx MC, Hulme SR, Broer S, Billups B. SNAT3-mediated glutamine transport in perisynaptic astrocytes in situ is regulated by intracellular sodium. Glia. 2017;65(6):900\u201316.","journal-title":"Glia"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-020-0178-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12987-020-0178-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-020-0178-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T01:00:10Z","timestamp":1612918810000},"score":1,"resource":{"primary":{"URL":"https:\/\/fluidsbarrierscns.biomedcentral.com\/articles\/10.1186\/s12987-020-0178-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,11]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["178"],"URL":"https:\/\/doi.org\/10.1186\/s12987-020-0178-x","relation":{},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,11]]},"assertion":[{"value":"28 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Male and female 8- to 16\u00a0weeks old wild type and LAT2 (<i>Slc7a8<\/i>) KO (24) C57BL\/6J mice were used (Charles River (Crl), Germany and in-house breeding). Animals were kept in standard cages under 12-h light\/dark cycle (7:00\u00a0h\/19:00\u00a0h) with free access to food and tap water. All animal experiments were conducted in accordance with the Swiss federal and cantonal law and performed with the approval of the Swiss Veterinary Council, Approval number 205\/2016.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17"}}